WGS2023: What Stands Between Vaccine Development and its Availability to the Public?

Dr. Roger Kornberg, Nobel Laureate in chemistry: "The chief obstacle is regulatory, these medicine are available now. All that stands between that, and its availability to the population, are regulatory hurdles.

When the next pandemic strikes, which could be as soon as tomorrow, we have the capacity to determine the sequence of the new virus and make that medicine overnight, and protect the entire population—again.

All that stands between that capability and its implementation is the slow pace, the bureaucracy, the risk-adverse nature of regulatory agencies. It is a broken system and it needs to be fixed"

Kornberg seemed to be unconcerned with potential harm from rolling out unsafe vaccine products.

????Source: World Government Summit
(https://twitter.com/WorldGovSummit/status/1625835405193912320?t=F1oJOEWVOfgwcMQMUFJDcg&s=19)

???? Follow:@G3News
#vaccines #pandemic #WGS2023 #vaccinesideeffects #vaccine #covid19
WGS2023: What Stands Between Vaccine Development and its Availability to the Public? Dr. Roger Kornberg, Nobel Laureate in chemistry: "The chief obstacle is regulatory, these medicine are available now. All that stands between that, and its availability to the population, are regulatory hurdles. When the next pandemic strikes, which could be as soon as tomorrow, we have the capacity to determine the sequence of the new virus and make that medicine overnight, and protect the entire population—again. All that stands between that capability and its implementation is the slow pace, the bureaucracy, the risk-adverse nature of regulatory agencies. It is a broken system and it needs to be fixed" Kornberg seemed to be unconcerned with potential harm from rolling out unsafe vaccine products. ????Source: World Government Summit (https://twitter.com/WorldGovSummit/status/1625835405193912320?t=F1oJOEWVOfgwcMQMUFJDcg&s=19) ???? Follow:@G3News #vaccines #pandemic #WGS2023 #vaccinesideeffects #vaccine #covid19
Like
3
0 Comments 0 Shares 2455 Views